Company Profile
Updated: 13-NOV-09Cambridge Antibody Technology Group PLC
Non-Quoted Public Company
Milstein Bldg., Granta Park, Cambridge, CB21 6GH, United Kingdom
()44 01223 471 471, 44 01223 471 472 fax, http://www.cambridgeantibody.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Research, development and exploitation of products in the field of molecular engineering
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Adimab's Yeast-Based Antibody Platform Nabs Two More Deals.
BIOWORLD Today; 12/17/2009; 1157 words; ...else can: a technology that allows...fully-human antibodies." Those...panel of antibodies to Merck...fully human antibodies against a...average for antibody discovery...recent years. Cambridge Antibody Technology Group plc was bought...
Other News To Note.
BIOWORLD Today; 12/16/2009; 888 words; ...agreement with Lonza Group Ltd., of Basel...affinity monoclonal antibody in late preclinical...Biosciences Inc., of Cambridge, Mass., received...52861).) o Life Technologies Corp., of Carlsbad...o Oxford BioMedica plc, of Oxford, UK...company's LentiVector technology and is partnered ...
Biogen, Celltech To Collaborate On Crohn's Disease Product.
BIOWORLD Today; 11/4/2009; 1378 words; ...agreement with Celltech Group plc to collaborate on...anti-TNF-alpha antibody product, CDP 571...profits henceforth, Cambridge, Mass.-based...associated with the technology transfer to North...partner, Elan Corp. plc, of Dublin, Ireland...
Celltech Gains Clear Advantage In Bid For Oxford GlycoSciences.
BIOWORLD Today; 11/4/2009; 803 words; ...outstanding offer from Celltech Group plc is not a viable proposition...with London-based Marconi plc, a telecommunications equipment...OGS was sparked on Jan. 23. Cambridge Antibody Technology Group plc, of Cambridge, announced an...
Chromos Enters Licensing Deal With CAT For Antibody Work.
BIOWORLD Today; 11/4/2009; 1200 words; ...signing up with Cambridge Antibody Technology Group plc, which will...manufacture antibodies and biologics. CAT, of Cambridge, UK, will...monoclonal antibodies. The company...monoclonal antibody market is...GlycoSciences plc, of Oxford...
Recent News Articles
- UK biopharmaceutical company, Cambridge Antibody Technology has licensed its CAT-213 human monoclonal antibody to Canadian biotech concern iCo Therapeutics (Vancouver, British Columbia) for development and commercialization.(Collaborations in brief)(Cambridge Antibody Technology Group PLC)(Brief article)
Chemistry and Industry - January 29, 2007 - Promotions at Cambridge Antibody Techology.(promotions of Ian Anderson, Gaynor Fryers and Andy Williams at Cambridge Antibody Technology Group PLC)(Brief article)
Pharma Marketletter - December 18, 2006 - CAT exclusively licenses Debiopharm Ab.(licencing agreements of Cambridge Antibody Technology Group PLC and Debiopharm S.A.)(Brief article)
Pharma Marketletter - October 23, 2006 - The UK Department of Trade & Industry (DTI) has awarded a technology programme collaborative R&D grant to a biotech consortium led by consultancy BioPharm Services and supported by biopharmacentical companies Avecia and Cambridge Antibody Technology, to develop a knowledge management model to help biopharmaceutcial companies bring new products from development to manufacture.(Projects & Technology)(Cambridge Antibody Technology Group PLC)(Brief article)
Chemistry and Industry - October 16, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning